Kynam Capital Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001907884

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q2 2025 · 31 positions · Total reported value $928.82M · Top-10 concentration 77.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 48.8% · 4 new · 7 cut · 9 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +14.0% · vs SPY -0.8% · Prev Value $1.55B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2025 13F filing, Kynam Capital Management, LP disclosed 31 equity positions with a combined reported value of $928.82M. The filing implies a focused portfolio: its ten largest positions account for 77.4% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were CLDX ($124.15M), PCVX ($99.86M), VERA ($80.74M). By sector, the heaviest allocations are Health Care 97.7%, Other 2.3%. Versus the prior quarter, allocation shifted toward Health Care (+2.4pp) and away from Other (-2.4pp).

Versus the prior quarter, Kynam Capital Management, LP opened 4 new positions, trimmed 7 and fully exited 9, a turnover rate of 48.8% of positions. The portfolio's overlap with the prior quarter was 85% of names.

The largest new positions opened in Q2 2025 were CTMX ($4.89M), EWTX ($3.33M).

Of the 9 positions fully exited versus the prior quarter, the largest were NTRA ($165.11M), SLNO ($21.61M), LEGN ($20.70M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • CTMX CYTOMX THERAPEUTICS INC. · $4.89M
  • EWTX EDGEWISE THERAPEUTICS INC COM · $3.33M

Fully Exited (vs previous quarter)

  • NTRA NATERA INC · prev qtr: $165.11M
  • SLNO SOLENO THERAPEUTICS INC · prev qtr: $21.61M
  • LEGN LEGEND BIOTECH CORP SPONSORED ADS · prev qtr: $20.70M · history

Insider Transactions (Form 4)

Latest Kynam Capital Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Kynam Capital Management, LP files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 32 positions worth $1.81B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • SEC registration: 801-126187 (status: Approved), registered 2022-07-22
  • Regulatory AUM (Form ADV): $2.41B as of 2026-04-10
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 32 positions · $1.81B reported value (Q2 2026)
  • Top 10 holdings = 72.7% of reported value
  • Largest position: CLDX (CELLDEX THERAPEUTICS INC NEW) at 10.9%
  • Average position size: $56.54M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 4 new, 12 added, 7 reduced, 9 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 97.7%
Other 2.3%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 6.10M $124.15M 13.37%
13.37%
Reduce
2 3.07M $99.86M 10.75%
10.75%
Reduce
3 3.43M $80.74M 8.69%
8.69%
Add
4 8.52M $79.79M 8.59%
8.59%
Hold
5 8.46M $75.84M 8.16%
8.16%
Reduce
6 2.46M $63.90M 6.88%
6.88%
Reduce
7 4.43M $61.90M 6.67%
6.67%
Reduce
8 8.49M $60.98M 6.57%
6.57%
Reduce
9 2.42M $41.12M 4.43%
4.43%
Reduce
10 976.27K $30.64M 3.30%
3.30%
Reduce
11 4.56M $29.64M 3.19%
3.19%
Reduce
12 1.54M $22.80M 2.46%
2.46%
Reduce
13 2.33M $22.30M 2.40%
2.40%
Reduce
14 2.15M $21.28M 2.29%
2.29%
Reduce
15 4.99M $18.18M 1.96%
1.96%
Hold
16 2.10M $15.76M 1.70%
1.70%
Reduce
17 1.17M $13.37M 1.44%
1.44%
Add
18 2.89M $9.99M 1.07%
1.07%
Reduce
19 576.11K $9.34M 1.01%
1.01%
Reduce
20 656.57K $9.00M 0.97%
0.97%
Add
21 2.15M $4.89M 0.53%
0.53%
New
22 3.46M $4.87M 0.53%
0.53%
Reduce
23 5.47M $3.92M 0.42%
0.42%
Reduce
24 3.07M $3.87M 0.42%
0.42%
Reduce
25 5.09M $3.63M 0.39%
0.39%
Reduce
26 1.03M $3.47M 0.37%
0.37%
Add
27 1.65M $3.36M 0.36%
0.36%
Reduce
28 253.98K $3.33M 0.36%
0.36%
New
29 994.88K $3.14M 0.34%
0.34%
Hold
30 200.05K $2.49M 0.27%
0.27%
Reduce
31 1.03M $1.28M 0.14%
0.14%
Reduce

FAQ

What did Kynam Capital Management, LP buy in 2025-Q2?

In its 2025-Q2 13F filing, Kynam Capital Management, LP reported 31 equity positions worth $928.82M in aggregate; its largest disclosed positions were CLDX ($124.15M), PCVX ($99.86M), VERA ($80.74M).

How large is Kynam Capital Management, LP's portfolio?

Kynam Capital Management, LP reported $928.82M of long equity holdings across 31 positions as of 2025-Q2. Top-10 holdings account for 77.4% of reported value.

What is Kynam Capital Management, LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/kynam-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →